Tag: Kaléo
FDA Approves Auvi-Q with Lower Dose for Infants and Small Children
New variant also has smaller needle size to prevent hitting bone during administration.
‘No Appetite for Bullying’ Food Allergy Anti-Bullying Campaign Launches
Initiative is intended to raise awareness about the prevalence and potential dangers of food allergy bullying.
Kaleo Donates Thousands of Epinephrine and Naloxone Auto-Injectors to Hurricane Harvey...
Direct Relief to distribute 25,000 auto-injectors to partner clinics serving storm-impacted communities.
Kaléo Launches Program to Provide Free Epinephrine Auto-Injectors to Schools
"Q for Schools" program will provide stock epinephrine to public elementary schools nationwide.
FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...
The new epinephrine auto-injector would feature a lower dose and shorter needle length suitable for smaller children.
Auvi-Q Takes Center Stage at School Nurse Conference
One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.
Welcome Symjepi™: Adamis’ Prefilled Epinephrine Syringe Receives FDA Approval
The additional competition should help lower costs across the emergency epinephrine market.
Kaléo Sued Over Evzio, an Auto-Injector With Pricing Structure Similar to...
Arcane system of pricing and insurance rebates at heart of the suit.
Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy
More legal troubles for the embattled marketer of EpiPen.
Kmart Announces Lower Price of Adrenaclick Generic
May cost as low as $0 to consumers with commercial health insurance.
